ALK POSITIVE
Clinical trials for ALK POSITIVE explained in plain language.
Never miss a new study
Get alerted when new ALK POSITIVE trials appear
Sign up with your email to follow new studies for ALK POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests the safety and best dose of two drugs, ceritinib and everolimus, given together to adults with advanced solid tumors or a specific type of lung cancer (ALK-positive NSCLC). The goal is to find a dose that controls tumor growth with manageable side eff…
Matched conditions: ALK POSITIVE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:40 UTC
-
Targeted pill after lung cancer surgery may keep the disease from coming back
Disease control OngoingThis study looks at whether taking crizotinib after surgery can help people with early-stage ALK-positive lung cancer live longer without the cancer returning. About 166 people who had their lung cancer removed will either take crizotinib or just be watched. The goal is to see if…
Matched conditions: ALK POSITIVE
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 22, 2026 13:53 UTC